eli lilly retatrutide Lilly's tirzepatide showed positive results in late-stage trial as treatment for heart failure Eli Lilly's tirzepatide showed positive
Description
Lyophilized research material for laboratory use only
Scientifically Backed for Real Results: Clinical studies show that 10g (the amount in 4 tsp) helps promote satiety within 30 minutes after a meal and helps maintain appetite control for up to 4 hours.* Designed for convenient daily use
In the ACHIEVE-1 phase 3 trial, the oral small-molecule GLP-1 receptor agonist orforglipron significantly reduced the glycated hemoglobin level over a period of 40 weeks in adults with early type 2 diabetes
High-Purity Standards
Key information on GLP-1 research peptides for labs
